Mar 08, 2022 / 06:05PM GMT
Jayson Tyler Bedford - Raymond James & Associates, Inc., Research Division - Senior Medical Supplies and Devices Analyst
National Women's Day. So with us, we have the senior management team of Johnson & Johnson, the largest health care company in the world. We have the company's CFO, Joe Wolk. We have the company's VP, Investor Relations, Jess Moore. And we also have Lisa Romanko upfront here. So with that, I'm going to give Joe a couple of minutes just to talk about why he's excited about J&J's positioning and what excites him going forward, and then we'll jump into Q&A.
Joseph J. Wolk - Johnson & Johnson - Executive VP & CFO
Great. Thanks, Jayson. Certainly, it's a pleasure to be here with all of you here in the room in person. I want to compliment and congratulate Raymond James. This is the first health care conference that I've been in-person at -- in probably 2 years, and I imagine many in the room could say the same thing. Listen, Jayson, I think there's a lot of reasons to be excited about Johnson & Johnson's business moving
Johnson & Johnson at Raymond James Institutional Investors Conference Transcript
Mar 09, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers